Indian Immunologicals nasal COVID vaccine a 'gamechanger': Study MD Bureau27 Aug 2024 11:55 AM ISTNew Delhi: A new nasal, needle-free COVID-19 vaccine, licensed to Hyderabad-based Indian Immunologicals, is expected to be a significant...
Havisure: India's first indigenously developed Hepatitis A vaccine launched Ruchika Sharma20 Jan 2024 2:23 PM ISTIt is a two-dose vaccine wherein the first dose is administered at 12 months of age and the second dose is given at least 6 months after the first...
Indian Immunologicals starts work on veterinary vaccine facility in Hyderabad Ruchika Sharma31 Dec 2023 1:00 PM ISTThe proposed facility has a capacity of 150 million doses per annum of FMD vaccine or FMD plus HS vaccine each.
Indian Immunologicals expects to commercially launch dengue fever vaccine by early 2026 Ruchika Sharma27 Aug 2023 12:30 PM ISTIIL's managing director, K Anand Kumar, said the vaccine's early stage trials conducted on about 90 individuals, aged 18-50 years, did not demonstrate...
Indian Immunologicals wins DCGI okay to manufacture Measles-Rubella vaccine Ruchika Sharma28 March 2023 2:15 PM ISTThis vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years, it said.
Indian Immunologicals launches its first set of virtual medical representatives Ruchika Sharma14 Feb 2023 2:15 PM ISTHyderabad: The healthcare sector in India is leaping forward with digital innovations at an accelerated pace. Government of India's initiatives like...
Indian Immunologicals to infuse Rs 700 crore to set up animal vaccine facility in Genome Valley Ruchika Sharma11 Oct 2022 2:30 PM ISTIL's intended new facility, in Genome Valley Phase 3, will add another 300 million doses/annum of FMD vaccine to its capacity.
Indian Immunologicals arm inaugurates new sterile filtered serum manufacturing facility in Dargaville Ruchika Sharma11 July 2022 5:07 PM ISTPristine has been able to produce and supply several hundred tonnes of Quality serum to Indian Immunologicals Ltd (IIL) in India and other countries
Indian Immunologicals to invest Rs 75 crore for viral antigen manufacturing plant in Telangana Ruchika Sharma26 Nov 2020 4:18 PM ISTThe company plans to utilise the facility to manufacture COVID-19 vaccines post completion of its R&D with Griffith University, Australia, IIL added.
